Viewing Study NCT00722592


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-01-01 @ 12:22 PM
Study NCT ID: NCT00722592
Status: COMPLETED
Last Update Posted: 2015-01-07
First Post: 2008-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)
Sponsor: Endocyte
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module